The Claim
Genetically reduced PCSK9 function is associated with a 24% lower risk of abdominal aortic aneurysm (AAA) in a trans-ethnic population of 312,097 individuals, with an odds ratio of 0.76 (95% CI: 0.68–0.86, p = 2.9 × 10⁻⁶), suggesting that lifelong lower LDL cholesterol due to inherited PCSK9 variation may confer protection against AAA.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People born with a certain genetic quirk that lowers their bad cholesterol over their whole life seem to have a lower chance of developing a dangerous belly blood vessel problem called an abdominal aortic aneurysm.
See the scientific wording
Genetically reduced PCSK9 function is associated with a 24% lower risk of abdominal aortic aneurysm (AAA) in a trans-ethnic population of 312,097 individuals, with an odds ratio of 0.76 (95% CI: 0.68–0.86, p = 2.9 × 10⁻⁶), indicating that lifelong lower LDL-C due to PCSK9 variation may protect against this life-threatening vascular condition.
What the research says
1 studyThe study looked at people with natural changes in the PCSK9 gene that lower bad cholesterol, and found they had a 24% lower risk of a dangerous belly artery problem, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.